Thank you for the question.
Obviously, this was very much in the public discourse and in the spotlight last week. We were monitoring this very actively and we received a lot of media inquiries as well.
Because of our confidentiality obligations, all I can say with respect to that agreement is that it was very much on our radar, in part because protecting access to, and affordability of, prescription drugs is an absolute priority and is important for Canadians. These are things that were very much top of mind when they came to be known.
Coming back to Mr. MacGregor's question on this point, I'll just add that this is one where we've seen the discourse around competition and the backlash perhaps showing that we're really prioritizing competition more in our economy. From our perspective, that's certainly a welcome change.